First Time Loading...
L

Lucira Health Inc
NASDAQ:LHDX

Watchlist Manager
Lucira Health Inc
NASDAQ:LHDX
Watchlist
Price: 0.0339 USD -19.29% Market Closed
Updated: Mar 28, 2024

Profitability Summary

Lucira Health Inc's profitability score is 17/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

17/100
Profitability
Score
17/100
Profitability
Score

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Lucira Health Inc

Revenue
212.1m USD
Cost of Revenue
-246.1m USD
Gross Profit
-34m USD
Operating Expenses
-102.9m USD
Operating Income
-136.9m USD
Other Expenses
-6.4m USD
Net Income
-143.3m USD

Margins Comparison
Lucira Health Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Lucira Health Inc
NASDAQ:LHDX
1.4m USD
-16%
-65%
-68%
US
Abbott Laboratories
NYSE:ABT
196.7B USD
55%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
140.9B USD
66%
25%
25%
US
Stryker Corp
NYSE:SYK
136.1B USD
64%
21%
15%
IE
Medtronic PLC
NYSE:MDT
116.1B USD
66%
20%
13%
US
Boston Scientific Corp
NYSE:BSX
100.6B USD
70%
17%
11%
US
Becton Dickinson and Co
NYSE:BDX
71.3B USD
41%
11%
6%
DE
Siemens Healthineers AG
XETRA:SHL
63.4B EUR
36%
10%
7%
US
Edwards Lifesciences Corp
NYSE:EW
57.3B USD
77%
29%
23%
US
Dexcom Inc
NASDAQ:DXCM
53.8B USD
64%
17%
15%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
338.5B CNY
65%
36%
33%
Country US
Market Cap 1.4m USD
Gross Margin
-16%
Operating Margin
-65%
Net Margin
-68%
Country US
Market Cap 196.7B USD
Gross Margin
55%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 140.9B USD
Gross Margin
66%
Operating Margin
25%
Net Margin
25%
Country US
Market Cap 136.1B USD
Gross Margin
64%
Operating Margin
21%
Net Margin
15%
Country IE
Market Cap 116.1B USD
Gross Margin
66%
Operating Margin
20%
Net Margin
13%
Country US
Market Cap 100.6B USD
Gross Margin
70%
Operating Margin
17%
Net Margin
11%
Country US
Market Cap 71.3B USD
Gross Margin
41%
Operating Margin
11%
Net Margin
6%
Country DE
Market Cap 63.4B EUR
Gross Margin
36%
Operating Margin
10%
Net Margin
7%
Country US
Market Cap 57.3B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
23%
Country US
Market Cap 53.8B USD
Gross Margin
64%
Operating Margin
17%
Net Margin
15%
Country CN
Market Cap 338.5B CNY
Gross Margin
65%
Operating Margin
36%
Net Margin
33%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Lucira Health Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Lucira Health Inc
NASDAQ:LHDX
1.4m USD
-112%
-70%
-91%
-125%
US
Abbott Laboratories
NYSE:ABT
196.7B USD
15%
8%
11%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
140.9B USD
15%
13%
14%
18%
US
Stryker Corp
NYSE:SYK
136.1B USD
18%
8%
14%
11%
IE
Medtronic PLC
NYSE:MDT
116.1B USD
8%
5%
8%
6%
US
Boston Scientific Corp
NYSE:BSX
100.6B USD
9%
5%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
71.3B USD
5%
2%
5%
4%
DE
Siemens Healthineers AG
XETRA:SHL
63.4B EUR
8%
3%
7%
4%
US
Edwards Lifesciences Corp
NYSE:EW
57.3B USD
23%
16%
23%
23%
US
Dexcom Inc
NASDAQ:DXCM
53.8B USD
26%
9%
15%
16%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
338.5B CNY
34%
25%
34%
42%
Country US
Market Cap 1.4m USD
ROE
-112%
ROA
-70%
ROCE
-91%
ROIC
-125%
Country US
Market Cap 196.7B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
10%
Country US
Market Cap 140.9B USD
ROE
15%
ROA
13%
ROCE
14%
ROIC
18%
Country US
Market Cap 136.1B USD
ROE
18%
ROA
8%
ROCE
14%
ROIC
11%
Country IE
Market Cap 116.1B USD
ROE
8%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 100.6B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
6%
Country US
Market Cap 71.3B USD
ROE
5%
ROA
2%
ROCE
5%
ROIC
4%
Country DE
Market Cap 63.4B EUR
ROE
8%
ROA
3%
ROCE
7%
ROIC
4%
Country US
Market Cap 57.3B USD
ROE
23%
ROA
16%
ROCE
23%
ROIC
23%
Country US
Market Cap 53.8B USD
ROE
26%
ROA
9%
ROCE
15%
ROIC
16%
Country CN
Market Cap 338.5B CNY
ROE
34%
ROA
25%
ROCE
34%
ROIC
42%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More